Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CCL19 suppresses gastric cancer cell proliferation, migration, and invasion through the CCL19/CCR7/AIM2 pathway
Rui Zhou, Jun Sun, Chunping He, et al.
Human Cell (2020) Vol. 33, Iss. 4, pp. 1120-1132
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Pyroptosis in health and disease: mechanisms, regulation and clinical perspective
Yifan Liu, Renjie Pan, Yuzhen Ouyang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 40
Role of tertiary lymphoid structures and B cells in clinical immunotherapy of gastric cancer
Wei‐Yi Chen, Lingli Zhang, Man Gao, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
Does CCL19 act as a double-edged sword in cancer development?
Arezoo Gowhari Shabgah, Zaid Al-Obaidi, Heshu Sulaiman Rahman, et al.
Clinical & Experimental Immunology (2021) Vol. 207, Iss. 2, pp. 164-175
Open Access | Times Cited: 53
Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer
Pengju Gong, You-Cheng Shao, Sirui Huang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 43
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential
Adriana Carino, Luigina Graziosi, Silvia Marchianò, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 28
No Time to Die: How Kidney Cancer Evades Cell Death
Carlo Ganini, Manuela Montanaro, Manuel Scimeca, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6198-6198
Open Access | Times Cited: 17
The dual roles of human PYHIN family proteins in cancer: mechanisms and therapeutic implications
Shuyan Zeng, Zhiyong Zhou, Yi Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Effects of Inflammation on the Immune Microenvironment in Gastric Cancer
Weidan Zhao, Mingqing Liu, Mingyue Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 23
Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation
Yan Qin, Pan Liu-xian, Tianyu Qin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
CCL19 has potential to be a potential prognostic biomarker and a modulator of tumor immune microenvironment (TIME) of breast cancer: a comprehensive analysis based on TCGA database
Jin‐Yan Wang, Dongmei Qin, Lingling Ye, et al.
Aging (2022) Vol. 14, Iss. 9, pp. 4158-4175
Open Access | Times Cited: 12
CC chemokine receptor 7 promotes macrophage recruitment and induces M2-polarization through CC chemokine ligand 19&21 in oral squamous cell carcinoma
Wanhang Zhou, Yao Wang, Yan Cong, et al.
Discover Oncology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Downregulation of dermatopontin in cholangiocarcinoma cells suppresses CCL19 secretion of macrophages and immune infiltration
Peng Xu, Siyang Li, Ke Liu, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 2
Open Access | Times Cited: 2
Pyroptosis Patterns Characterized by Distinct Tumor Microenvironment Infiltration Landscapes in Gastric Cancer
Renshen Xiang, Yuhang Ge, Wei Song, et al.
Genes (2021) Vol. 12, Iss. 10, pp. 1535-1535
Open Access | Times Cited: 16
Comprehensive Analysis of Myeloid Signature Genes in Head and Neck Squamous Cell Carcinoma to Predict the Prognosis and Immune Infiltration
Zhifeng Liu, Diekuo Zhang, Chao Liu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 15
Construction of ceRNA prognostic model based on the CCR7/CCL19 chemokine axis as a biomarker in breast cancer
Rufei Ma, Xiuliang Guan, Nan Teng, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Comprehensive analysis of pyroptosis regulators and tumor immune microenvironment in clear cell renal cell carcinoma
Yan Zhang, Xianwu Chen, Qinghe Fu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 14
The association between plasma chemokines and breast cancer risk and prognosis: A mendelian randomization study
Xingxing Yu, Yanyu Zhang, Yuxiang Lin, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 5
Advances in Research on the Effects and Mechanisms of Chemokines and Their Receptors in Cancer
Jing Xu, Jingquan Li, Qilei Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Harnessing cytokines to optimize chimeric antigen receptor-T cell therapy for gastric cancer: Current advances and innovative strategies
Zewei Cheng, Xiaohan Cui, Song Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117229-117229
Open Access | Times Cited: 1
Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapy
Yu Zhou, Shasha Wang, Yunxia Tao, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Shared network pattern of lung squamous carcinoma and adenocarcinoma illuminates therapeutic targets for non-small cell lung cancer
Piaopiao Li, Xuemei Kuang, Tingting Zhang, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access | Times Cited: 5
Absent in melanoma 2 suppresses gastric cancer cell proliferation and migration via inactivation of AKT signaling pathway
Dong Wang, Junwei Zou, Jun Dai, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 6
Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer
Giorgio Malpeli, Stefano Barbi, Giulio Innamorati, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 12, pp. 2006-2006
Open Access | Times Cited: 3
Exploring MiR-484 Regulation by Polyalthia longifolia: A Promising Biomarker and Therapeutic Target in Cervical Cancer through Integrated Bioinformatics and an In Vitro Analysis
Jiaojiao Niu, Yeng Chen, Hwa Chia Chai, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 909-909
Open Access
CCL19 has potential to be a prognostic biomarker and a modulator of tumor immune microenvironment (TIME) of breast cancer: a comprehensive analysis based on TCGA database
Jinyan Wang, Jinqiu Wang, Quan Gu, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top